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Vasodilation Inhibitors in Patients With Raynaud 's Phenomenon 
Sin ce patients w ith Raynaud 's pheno menon l13ve ep isodes of di g-
ita l vasos pas ms w hen they arc cold o r em otionall y stressed, a 
n umber o f in ves tigators have proposed that these patients may 
produ ce a substance th at preven ts blood vessels from dilating. In 
this issue, Malco lm Ru stin , Helen Bu ll , Sa muel Machin , Osa mu 
Koro, and Paulin e Dowd of the Middlesex Hos pital in Lond on 
report evidence in support of this hypothesis. Serum from Ray-
na ud 's patients, they fi nd, inhibits pros ta cyclins, w hi ch are potent 
vasodil ato rs. 
Dowd says that she and her colleagues decided to look for 
prostacyclin inhibitors in the serum of Raynaud 's patients beca use 
th ere had been previous 'sugges tions th at defects in the actions of 
prostacyclins mi ght be partiall y res ponsible for the lack of vaso-
d ilation. In addition, Dowd notes, prostacycl in itself seem s to 
help Ray naud's patients. It is fa r from an idea l treatment, how-
ever, since it must be g iven by infusion; it is "exceedin g ly ex-
pensive , and the side effects are dreadful," Dowd says. Prostacyclin 
infusions ca use headaches, hypertension, and nausea. These side 
effects go away w hen the infusion is sto pped. The pati ents' con-
ditio n is better afterwa rd and the symptoms of Raynaud 's phe-
no menon are relieved. 
Rustin , Bu ll , Machin , Koro, and Dowd studied serum from 
normal volun teers, from patients with primary Raynaud 's phe-
nomenon, and from pat ients w ith Raynaud 's phenomenon in 
association w ith sys temi c sclerosis. All the sera inhibited the re-
lease of pros tacycl ins from cultured endothelial cell s, but the sera 
from the Raynaud 's patients inhibited prostacyclin release to a far 
grea ter degree. 
The researchers have so fa r been unable to identify the pros-
tacyclin inhibi to r in th e serum of Raynaud 's patients. " It does 
not :l ppea r to be an iml11une complex," says Dowd, "and it always 
seems to be present." Dowd suggests th at this serologic fac tor 
might inhibit other vasod ilato rs in addition to prostacyclins, but 
even if it inhibits pros tacy clins alone, it co uld be a m ajo r con-
tributor to the pathophysio logy of Raynaud 's phenom enon. 
Understanding H emangiomas 
Adult hemangiomas, repo rts a g roup fro m Stanfo rd University 
Schoo l of M edicine, are di fferent from many other neo plasm s. 
In thi s issue, Rubin Tuder, Robert Young, Marvin Karasek, and 
Klaus Bensch argue th at heman giomas co nsist of non rep li ca tin g, 
res ting cells that are :It a terminal stage of cellular differentiation . 
The group began its wo rk thinkin g that hemangioma cell s 
closely resembled normal end othelial cells in th eir growth char-
acteristics and th at it would be possible to stud y hem angiom as 
wi th a cell culture sys tem that is used for the g rowth of human 
endoth eli al cells. "We had the idea that we could induce g rowth 
of adult heman gio mas in vitro," says Tuder. "But we were un-
s u ccessful. We tried 14 tim es , but we could not get the cells to 
grow." 
So th e group changed its hypoth es is. T he resea rchers proposed 
tha t the heman gio ma cell s are in a different stage of g rowth than 
no rmal cell s and that the hem angioma cells may in fact be at an 
end stage of differentiation. 
To in ves ti gate thi s hypo thesis, the gro up looked w ith electron 
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microsco py at 156 vessels from 9 hem angiomas . There were no 
sites of active blood vessel formation, which was co nsistent w ith 
th e idea that the hemangiomas were at a termin al stage of growth. 
The in vestigators also noticed that the base ment membrane of 
the hemangiomas was thickened and collagen flbrils were grow-
in g fro l11 th e dermis into the basement membrane. The heman-
gioma vessels, says Tuder, "wouldn ' t collapse for yea rs." 
N ex t, the resea rchers used an immunohistochemi cal marker 
that binds specifi cally to actively growing cells. The hem.angioma 
cells " didn't stain at all ," T uder reports. 
Finally , the in ves tiga to rs tri ed to stain the hem angioma cells 
w ith a monoclonal antibody that is specifi c fo r proli ferating endo-
thelia l cells. O nce again, says Tuder, " the vessels didn't stain. " 
These res ults, Tuder concludes, "sugges t strongly that endo-
theli al cells in hemangiomas, instead of ra pidl y proliferating, are 
in almost a resting sta te. O ur res ults impl y that the cells are no t 
growing at all in ad ult hemangiomas . " 
